Viewing StudyNCT05389462



Ignite Creation Date: 2024-05-06 @ 5:40 PM
Last Modification Date: 2024-10-26 @ 2:33 PM
Study NCT ID: NCT05389462
Status: RECRUITING
Last Update Posted: 2024-04-18
First Post: 2022-05-20

Brief Title: A Study of Mipasetamab Uzoptirine ADCT-601 in Participants With Solid Tumors
Sponsor: ADC Therapeutics SA
Organization: ADC Therapeutics SA

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Keywords:
Name View
NSCLC View
Advanced solid tumors View
Mipasetamab uzoptirine View
ADCT-601 View
Sarcoma View
Gemcitabine View
AXL View
Pancreatic cancer View